Clinical trial
Hormone Therapy Plus Radiation Therapy in Treating Patients With Prostate Cancer
NCT00003124 · Herbert Irving Comprehensive Cancer Center, Other · Completed
Key facts
| NCT number | NCT00003124 |
|---|---|
| Title | Hormone Therapy Plus Radiation Therapy in Treating Patients With Prostate Cancer |
| Official title | Phase II Trial of Maximal Androgen Deprivation Followed by Conformal External Beam Radiotherapy With Continued Androgen Deprivation for Clinically Localized Prostate Cancer |
| Lead sponsor | Herbert Irving Comprehensive Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug, Radiation |
| Interventions | flutamide, leuprolide acetate, radiation therapy |
| Enrollment | 105 |
| Start date | May 1, 1997 |
| Completion | Jan 1, 2007 |
| First posted | Apr 18, 2003 |
| Last update posted | Jan 6, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: